Pharmacokinetics and pharmacodynamics of gliclazide in Caucasians and Australian Aborigines with type 2 diabetes-Reference-Cited by-同舟云学术

Pharmacokinetics and pharmacodynamics of gliclazide in Caucasians and Australian Aborigines with type 2 diabetes

Published:2000-03 Issue:3 Volume:49 Page:223-230
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:

Author:

Davis Timothy M. E.,Daly Frank,Walsh John P.,Ilett Kenneth F.,Beilby John P.,Dusci Leon J.,Barrett P. Hugh R.

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2125.2000.00162.x/fullpdf

Reference27 articles.

1. Gliclazide. An update of its pharmacological properties and therapeutic efficacy in non-insulin-dependent diabetes mellitus;Palmer;Drugs,1993

2. Influence of blood proteins on biomedical analysis. III. Pharmacokinetics and protein binding of gliclazide;Kobayashi;J Pharmacobiodynamics,1981

3. Forette B Rolland A Hopkins Y Gordon B Campbell B. Gliclazide pharmacokinetics in the elderly. 11th Congress of the International Diabetes Federation, 1982, Nairobi Excerpta Medica 1982; 8 9

4. Serum gliclazide concentration in diabetic patients. Relationship between gliclazide and serum concentration;Shiba;Diabetes Res Clin Pract,1986

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Low-Dose Sulfonylurea Plus DPP4 Inhibitor Lower Blood Glucose and Enhance Beta-Cell Function Without Hypoglycemia;The Journal of Clinical Endocrinology & Metabolism;2024-01-24

2. Computer-aided biopharmaceutical characterization: Gastrointestinal absorption simulation;Computer-Aided Applications in Pharmaceutical Technology;2024

3. Combination low dose sulphonylurea and DPP4 inhibitor have potent glucose lowering effect through augmentation of beta cell function without increase in hypoglycaemia: a randomised crossover study;2023-08-24

4. Impact of Mobile Radiations on Gliclazide Tablet Formulation;International Journal of Pharmaceutical Investigation;2023-07-08

5. Optimal dosing of gliclazide—A model‐based approach;Basic & Clinical Pharmacology & Toxicology;2023-04-22